B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
2 clinical trials · Condition
◉ Watch B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations (NCT02883049) | National Cancer Institute (NCI) | 2012-02-29 |
Track B Acute Lymphoblastic Leukemia, BCR-ABL1-Like automatically
Every clearance here is in the API, with alerts when new ones post.